Carriage of Ser217Leu and Ala541Thr Variants of ELAC2 Gene and Risk Factors in Patients with Prostate Cancer in Burkina Faso
ADD Traoré, BD Ky, L Traoré, TM Zohoncon… - Prostate …, 2022 - Wiley Online Library
Background. Genetic factors are one of the significant contributors to prostate cancer (PCa)
development, and hereditary prostate cancer 2 (HPC2) locus gene ELAC2 is considered a …
development, and hereditary prostate cancer 2 (HPC2) locus gene ELAC2 is considered a …
Prevalence of the Ser217leu variant of the ELAC2 gene and its association with prostate cancer in population of the littoral region of Cameroon
ALZ Djomkam, T Beyeme Sala… - Prostate …, 2019 - Wiley Online Library
Background. HPC2/ELAC2 has been identified as a prostate cancer (PC) susceptibility
gene. Ser‐Leu changes at amino acid 217 have been one of the most studied variants of …
gene. Ser‐Leu changes at amino acid 217 have been one of the most studied variants of …
[PDF][PDF] Influence of GSTM1, GSTP1, and GSTT1 Gene Polymorphisms on Prostate Cancer Risk in Turkish Population.
We analysed glutathione S-transferase M1, T1, and P1 gene polymorphisms in a case
control study to asses their susceptibility to prostate cancer in Turkish population …
control study to asses their susceptibility to prostate cancer in Turkish population …
Роль некоторых полиморфных вариантов гена 5-альфаредуктазы в патогенезе рака предстательной железы
ИР Гилязова, ГБ Кунсбаева, АТ Мустафин… - Медицинский …, 2017 - cyberleninka.ru
В клетках предстательной железы тестостерон, первичный андроген у мужчин,
превращается с помощью фермента 5αредуктазы 2-го типа, который кодируется геном …
превращается с помощью фермента 5αредуктазы 2-го типа, который кодируется геном …
[PDF][PDF] Research Article Carriage of Ser217Leu and Ala541Thr Variants of ELAC2 Gene and Risk Factors in Patients with Prostate Cancer in Burkina Faso
ADD Traoré, BD Ky, L Traoré, T Zohoncon, AA Zouré… - 2022 - academia.edu
Background. Genetic factors are one of the significant contributors to prostate cancer (PCa)
development, and hereditary prostate cancer 2 (HPC2) locus gene ELAC2 is considered a …
development, and hereditary prostate cancer 2 (HPC2) locus gene ELAC2 is considered a …
Генетичний аналіз поліморфізму Val89Leu гена SRD5α2 та гена SRY у пацієнтів з порушенням диференціації статі
МЯ Тиркус, ГВ Макух, ММ Тенета… - Фактори …, 2016 - dspace.nbuv.gov.ua
Встановлено, що усі особи досліджуваної групи генетично чоловіки, але зовнішні
статеві органи не є чітко чоловічі чи жіночі. Тому актуальним видавалося дослідження …
статеві органи не є чітко чоловічі чи жіночі. Тому актуальним видавалося дослідження …
[图书][B] Identification of Potential Serum and Urine Biomarkers for Patients with Prostate Cancer Using Lectin-Based Proteomic Analyses
JJ Jayapalan - 2015 - search.proquest.com
The lack of specificity of prostate specific antigen emphasizes the need for a highly specific,
sensitive and reliable marker with effective diagnostic predictability in curbing prostate …
sensitive and reliable marker with effective diagnostic predictability in curbing prostate …
Identification of potential serum and urine biomarkers for patients with prostate cancer using lectin-based proteomic analyses/Jaime Jacqueline Jayapalan
J Jaime Jacqueline - 2015 - studentsrepo.um.edu.my
The lack of specificity of prostate specific antigen emphasizes the need for a highly specific,
sensitive and reliable marker with effective diagnostic predictability in curbing prostate …
sensitive and reliable marker with effective diagnostic predictability in curbing prostate …